Subclinical encephalopathy after conscious sedation with midazolam in cirrhotic patients? [10]

American Journal of Gastroenterology

Volumn 98, Issue 6, 2003, Pages 1450-1451

  Hourmand Ollivier, Isabelle ^a   Dao, Thong ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; MIDAZOLAM; PROPOFOL;

ANESTHESIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; GASTROINTESTINAL ENDOSCOPY; HEPATIC ENCEPHALOPATHY; HUMAN; LETTER; LIVER CIRRHOSIS; PRIORITY JOURNAL; SEDATION;

EID: 0038310783     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07505.x     Document Type: Letter

References (5)

1. Vasudevan AE, Goh KL, Bulgiba AM. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol 2002;7:1717-21.
2. Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Dig Dis 1977;22:541-50.
3. Quero JC, Hartmann IJC, Meulstee J, et al. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996;24:556-60.
4. Cohen D, Dubus L, Piquet MA, et al. Etude de la vigilance après anesthésie générale chez les sujets cirrhotiques. (Assessment of mental state after general anesthesia in cirrhotic patients). Gastroenterol Clin Biol 1997;21:A61 (abstract).
5. Assy N, Rosser BG, Grahame GR, et al. Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. Gastrointest Endosc 1999;49: 690-4.